ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 118,08
-0,95%
Dow Jones
39 806,77
0,00%
DAX
18 679,64
-0,47%
Brent Oil
82,085
-1,73%
Bitcoin
71 195,49
-0,36%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Arrowhead Pharmaceuticals Inc (ARWR)

  7. Arrowhead Pharmaceuticals Inc (ARWR) Actualités

ARWR

Arrowhead Pharmaceuticals (ARWR)

Arrowhead Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ARWR
DateHeureSourceTitreSymboleSociété
09/05/202422h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARWRArrowhead Pharmaceuticals Inc
07/05/202400h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
16/04/202415h00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/03/202423h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
27/02/202423h08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/02/202422h13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
17/01/202423h22Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
04/01/202423h01Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202322h09Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
27/06/202322h02Edgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
09/06/202320h17Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/05/202301h05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
21/03/202311h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
12/02/202317h30ValueWalkHere Are The Five Best- And Worst-Performing Mid-Cap Stocks In Jan. 2023NASDAQ:ARWRArrowhead Pharmaceuticals Inc
11/02/202316h22ValueWalkAshSwap the first stable-swap DEX Launches on MultiversX MainnetNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/02/202322h03Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/01/202322h47Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
20/01/202315h46Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/12/202212h04Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/11/202213h35TipRanksArrowhead Pharmaceuticals (ARWR) Gets a Buy from B.Riley FinancialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/11/202205h15TipRanksRobert W. Baird Remains a Buy on Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202221h25TipRanksArrowhead Pharmaceuticals (ARWR) Receives a Buy from JefferiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202217h25TipRanksMorgan Stanley Remains a Hold on Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
29/11/202214h50TipRanksAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR) and Boston Scientific (BSX)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
10/11/202215h05TipRanksB.Riley Financial Sticks to Its Buy Rating for Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
10/11/202213h36TipRanksArrowhead Pharmaceuticals (ARWR) Gets a Hold from SVB SecuritiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
10/11/202205h27TipRanksSVB Securities Sticks to Their Hold Rating for Arrowhead Pharmaceuticals (ARWR)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/11/202222h58TipRanksArrowhead to hold virtual analyst and investor eventNASDAQ:ARWRArrowhead Pharmaceuticals Inc
14/10/202213h15TipRanksArrowhead Pharmaceuticals (ARWR) Receives a Buy from B.Riley FinancialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
30/09/202223h33Edgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)NASDAQ:ARWRArrowhead Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ARWR

Dernières Valeurs Consultées

NYSE
NKE
Nike
EU
AI
Air Liquide
EU
EN
Bouygues
EU
RNO
Renault
EU
AF
Air FranceKLM
NASDAQ
GOOGL
Alphabet
NYSE
MCD
McDonalds
EU
ML
Michelin
EU
PX4
SBF 120
COIN
ETHUSD
Ethereum
EU
VIV
Vivendi
EU
GLE
Societe Generale
EU
SGO
Cie de SaintGobain
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés